Osilodrostat and Lumefantrine: Interaction Details
- Osilodrostat
- Isturisa
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Osilodrostat and Lumefantrine interaction:
Lumefantrine
We don't have a separate drug information page for Lumefantrine. The FDA's drug directory lists it as part of Coartem (artemether and lumefantrine). Read the Artemether and Lumefantrine drug information page → Have a question about Lumefantrine? Ask a pharmacist, free →
What Happens When You Take Osilodrostat With Lumefantrine
What can happen when they are taken together (rated Major)
Increased artemether/lumefantrine exposure and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Artemether/lumefantrine should not be given together with that also prolong the , osilodrostat being one example, because such a combination may raise artemether/lumefantrine exposure and thereby heighten the risk of QT interval prolongation. Caution is also warranted when giving any QT-prolonging drug after artemether/lumefantrine treatment has finished, since lumefantrine has a long (3 to 6 days).2
Osilodrostat causes dose-dependent QT interval prolongation. When the two drugs are used together, more frequent monitoring should be considered, and osilodrostat may need to be temporarily discontinued if the exceeds 480 milliseconds.1
The Osilodrostat and Lumefantrine Interaction, Explained
Taking these together may raise the risk of a heart rhythm problem. Lumefantrine (part of the malaria medicine artemether/lumefantrine) and osilodrostat (Isturisa, used for Cushing's disease) can each affect the heart's electrical timing, called the . Osilodrostat may also slow the breakdown of lumefantrine, so more of it may stay in your body. Lumefantrine also lingers for several days after your last dose.
This concern is based on how the drugs work rather than on reported cases. Don't change anything on your own. Tell your pharmacist or doctor about both medicines, so they can decide on the safest plan and check your heart rhythm if needed.
Mechanism: Osilodrostat is a , which may raise artemether/lumefantrine exposure. Both agents also prolong the , so the effects are . Osilodrostat causes dose-dependent . Lumefantrine has a long (3 to 6 days), so risk persists after the course ends.
- Direction: increased lumefantrine exposure and increased QT risk (magnitude not quantified).
- Evidence: theoretical. Onset unspecified. Severity: major.
- Management: avoid where possible. If used together, increase monitoring frequency. Consider temporary osilodrostat discontinuation if exceeds 480 ms. Use caution with QT-prolonging drugs after completing artemether/lumefantrine.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Osilodrostat and Lumefantrine Interact
The likely mechanism
of -mediated of artemether/lumefantrine;
How to Manage the Osilodrostat and Lumefantrine Interaction
Care teams usually try to avoid this combination. If both are truly needed, they may monitor you more closely, including more frequent heart tracings (ECGs).
- Keep taking your medicines as prescribed unless your doctor or pharmacist tells you otherwise.
- Tell your care team about every medicine you take, including ones started recently or for malaria.
- Remember that lumefantrine stays in the body for days after the last dose, so mention this if new medicines are started afterward.
- If your shows a longer , your doctor may decide to pause osilodrostat temporarily.
- Report fainting, dizziness, or a racing or irregular heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Osilodrostat or Lumefantrine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Osilodrostat and Lumefantrine: Common Questions
How serious is the Osilodrostat and Lumefantrine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Osilodrostat and Lumefantrine interaction managed?
Care teams usually try to avoid this combination. If both are truly needed, they may monitor you more closely, including more frequent heart tracings (ECGs). Keep taking your medicines as prescribed unless your doctor or pharmacist tells you otherwise. Tell your care team about every medicine you take, including ones started recently or for malaria. Remember that lumefantrine stays in the body for… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Osilodrostat and Lumefantrine Interaction
Ask in your own words about taking Osilodrostat and Lumefantrine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: ISTURISA(R) oral tablets, osilodrostat oral tablets. Recordati Rare Disease Inc (per FDA), Lebanon, NJ, 2020. DailyMed
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Osilodrostat and Lumefantrine
Also serious with Lumefantrine
- CarbamazepineContraindicated
- DronedaroneContraindicated
- FluconazoleContraindicated
- Fluconazole InjectionContraindicated
Also serious with Osilodrostat
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.